Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10560
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alvogen Inc (Alvogen) is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals, brand and over the counter (OTC) products. The company offers generic medications in the therapeutic areas of oncology, cardiology, respiratory, neurology and gastroenterology. It also provides services such as product development, contract manufacturing and research services. Alvogen’s OTC categories include food supplements, OTC medicines, cosmetics and medical devices. It offers products in various dosage forms of solid oral dosage, modified release tablets, soft gelatin capsules, creams, ointments, transdermals and injectables. The company operates through its manufacturing and development facilities located in the US, Taiwan, South Korea and Romania. Alvogen is headquartered in Pine Brook, New Jersey, the US.

Alvogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alvogen Inc, Medical Devices Deals, 2012 to YTD 2018 10
Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Alvogen Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Lotus Pharma Acquires Osteoporosis from Novartis 13
Alvogen Acquires Five Hormonal Products from Bayer Pharma 14
Alvogen to Acquire Four Pharma Products from Pfizer 15
Private Equity 16
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 16
Pamplona Capital Management Acquires Majority Stake In Alvogen 18
Partnerships 19
Alvogen Enters into Distribution Agreement with Theramex 19
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 20
Alvogen Enters into Marketing Agreement with AstraZeneca 21
Probi Enters Into Distribution Agreement With Alvogen 22
Licensing Agreements 23
Alvogen Enters into Licensing Agreement with Prestige BioPharma 23
Alvogen Malta Operations Enters into Licensing Agreement with Pfenex 24
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 25
Asset Transactions 26
Lotus Pharma Plans to Sell Product Rights 26
Acquisition 27
CVC Capital, Temasek and Vatera Healthcare May Sell Alvogen for up to USD4 Billion 27
Alvogen Acquires Omega Bittner from Perrigo for USD15 Million 28
Alvogen Acquires County Line Pharma 29
Alvogen Acquires Dream Pharma for USD184 Million 30
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 31
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 32
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 33
Alvogen Inc – Key Competitors 34
Alvogen Inc – Key Employees 35
Alvogen Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 38
Corporate Communications 38
Jan 16, 2018: Lotus Enters Management Team Integration With Alvogen – Petar Vazharov Steps Up As Lotus General Manager 38
Legal and Regulatory 39
Aug 10, 2018: Drugmaker sues, asks court to block use of its product in Nevada execution on Wednesday 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Alvogen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alvogen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Alvogen Inc, Medical Devices Deals, 2012 to YTD 2018 10
Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Lotus Pharma Acquires Osteoporosis from Novartis 13
Alvogen Acquires Five Hormonal Products from Bayer Pharma 14
Alvogen to Acquire Four Pharma Products from Pfizer 15
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 16
Pamplona Capital Management Acquires Majority Stake In Alvogen 18
Alvogen Enters into Distribution Agreement with Theramex 19
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 20
Alvogen Enters into Marketing Agreement with AstraZeneca 21
Probi Enters Into Distribution Agreement With Alvogen 22
Alvogen Enters into Licensing Agreement with Prestige BioPharma 23
Alvogen Malta Operations Enters into Licensing Agreement with Pfenex 24
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 25
Lotus Pharma Plans to Sell Product Rights 26
CVC Capital, Temasek and Vatera Healthcare May Sell Alvogen for up to USD4 Billion 27
Alvogen Acquires Omega Bittner from Perrigo for USD15 Million 28
Alvogen Acquires County Line Pharma 29
Alvogen Acquires Dream Pharma for USD184 Million 30
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 31
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 32
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 33
Alvogen Inc, Key Competitors 34
Alvogen Inc, Key Employees 35
Alvogen Inc, Subsidiaries 36

List of Figures
Alvogen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alvogen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alvogen Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seiko Optical Products Co Ltd:企業の戦略的SWOT分析
    Seiko Optical Products Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • LyondellBasell Industries NV (LYB)-石油・ガス分野:企業M&A・提携分析
    Summary LyondellBasell Industries N.V. (LyondellBasell) is a chemical company. It produces and sells petrochemicals, plastics and basic chemicals. The company also refines crude oil to convert into refined products such as gasoline, diesel and jet fuel. Its major chemical products include polyolefin …
  • Korea Electric Power Corporation (015760)-エネルギー分野:企業M&A・提携分析
    Summary Korea Electric Power Corporation (KEPCO) is an integrated electric utility. It generates, transmits, and distributes electricity. The company produces electricity in nuclear, thermal, hydro, and internal combustion power plants. Through power purchase agreements with independent power produc …
  • Axela Inc:医療機器:M&Aディール及び事業提携情報
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Avnet, Inc.:戦略・SWOT・企業財務分析
    Avnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • McCain Foods Ltd:戦略・SWOT・企業財務分析
    McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • WInco Foods LLC:戦略・SWOT・企業財務分析
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Protea Biosciences Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applica …
  • Vectura Group Plc (VEC):医療機器:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Tyler Technologies Inc (TYL):企業の財務・戦略的SWOT分析
    Tyler Technologies Inc (TYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Shinhan Bank:企業の戦略・SWOT・財務情報
    Shinhan Bank - Strategy, SWOT and Corporate Finance Report Summary Shinhan Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Citizens Electric Corporation:企業の発電所・SWOT分析2018
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • ERG SpA (ERG):電力:M&Aディール及び事業提携情報
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …
  • Fortis Inc.:企業の戦略・SWOT・財務分析
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Telefonaktiebolaget LM Ericsson:企業の戦略・SWOT・財務情報
    Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report Summary Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Axxam SpA-製薬・医療分野:企業M&A・提携分析
    Summary Axxam SpA (Axxam) is a partner research organization that provides drug discovery services. The organization offers drug discovery services such as molecular biology, assay development and reagent provision, compound management, hit characterization and profiling and electrophysiology, among …
  • Edwards Lifesciences Corp (EW):医療機器:M&Aディール及び事業提携情報
    Summary Edwards Lifesciences Corp (Edwards) is a medical technology company, which focuses on the development, manufacture and marketing of products and technologies to treat structural heart disease, and help provide critical care and surgical monitoring. It develops and commercializes heart valve …
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Palatin Technologies Inc (PTN):製薬・医療:M&Aディール及び事業提携情報
    Summary Palatin Technologies Inc (Palatin) is a biopharmaceutical company that undertakes the development of targeted, receptor-specific peptide therapeutics. The company’s development programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor sys …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆